Whole Exome Sequencing and RNA Sequencing of High Grade Serous Ovarian Cancer in Black and White Patients
Anthropometry (1)
- bmicat - BMI, kg/m2 (phv00542305.v1.p1)
Demographics (2)
- agecat - Age at diagnosis (phv00542306.v1.p1)
- SEX - Biological sex (phv00542293.v1.p1)
Race and Ethnicity (1)
- race - Self reported race (phv00542303.v1.p1)
Other (41)
- ANALYTE_TYPE - RNA or DNA (phv00542334.v1.p1)
- BODY_SITE - Tissue origin (phv00542333.v1.p1)
- clusterk2_kmeans - Kmeans, K=2 cluster for RNA-Seq (phv00542320.v1.p1)
- clusterk2_nmf - NMF, K=2 cluster for RNA-Seq (phv00542323.v1.p1)
- clusterk3_kmeans - Kmeans, K=3 cluster for RNA-Seq (phv00542321.v1.p1)
- clusterk3_nmf - NMF, K=3 cluster for RNA-Seq (phv00542324.v1.p1)
- clusterk4_kmeans - Kmeans, K=4 cluster for RNA-Seq (phv00542322.v1.p1)
- clusterk4_kmeans_tcga_names - Kmeans, K=4 cluster for RNA-Seq mapped to TCGA subtype names (phv00542326.v1.p1)
- clusterk4_nmf - NMF, K=4 cluster for RNA-Seq (phv00542325.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00542292.v1.p1)
- debulking - Debulking status, incorporating CA125 levels where residual disease is unknown (phv00542309.v1.p1)
- figo_seer_summary_stage - FIGO/SEER summary stage (phv00542304.v1.p1)
- file_id_noR - Full file id (phv00542314.v1.p1)
- genomic_type - Genomic source (phv00542313.v1.p1)
- IS_TUMOR - Whether or not sample is from tumor (phv00542335.v1.p1)
- neoadj - Neoadjuvant treatment (phv00542308.v1.p1)
- ran_in_way_pipeline - Whether this sample was used in the Way pipeline (phv00542319.v1.p1)
- rna_low_qual - Whether the RNA sample was low quality (phv00542317.v1.p1)
- rna_resequenced - Whether the RNA sample was resquenced (phv00542316.v1.p1)
- rna_sequencing_id - Reference RNA sequencing ID (phv00542315.v1.p1)
- rna_version - Whether the RNA sample was in the pilot stufy or the full study (phv00542318.v1.p1)
- SAMPLE_ID - Sample ID (phv00542311.v1.p1)
- SAMPLE_ID - Sample ID (phv00542332.v1.p1)
- SAMPLE_ID - Sample ID (phv00542301.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID in the source repository (phv00542295.v1.p1)
- SOURCE_SUBJECT_ID2 - Subject ID in the additional repository (phv00542297.v1.p1)
- SOURCE_SUBJECT_ID3 - Subject ID in the additional repository (phv00542299.v1.p1)
- study - SchildkrautB or SchildkrautW study (phv00542312.v1.p1)
- SUBJECT_ID - Subject ID (phv00542291.v1.p1)
- SUBJECT_ID - Subject ID (phv00542302.v1.p1)
- SUBJECT_ID - Subject ID (phv00542300.v1.p1)
- SUBJECT_SOURCE - Original source repository of subject (phv00542294.v1.p1)
- SUBJECT_SOURCE2 - Additional repository of subject (phv00542296.v1.p1)
- SUBJECT_SOURCE3 - Additional repository of subject (phv00542298.v1.p1)
- t1stage - FIGO stage (phv00542307.v1.p1)
- tsiorig - Tissue source (phv00542310.v1.p1)
- wes_concordance.check - Concordance between tumor and germline pair. Indicator that samples may have been switched. (phv00542330.v1.p1)
- wes_coverage.at.0.9.of.target.bps - Better measure of coverage, calculated by asking what fraction of target BPs have 0x, 1x, 2x or more coverage. Stop when it hits 0.9. (phv00542328.v1.p1)
- wes_coverage.at.0.95.of.target.bps - Better measure of coverage, calculated by asking what fraction of target BPs have 0x, 1x, 2x or more coverage. Stop when it hits 0.95. (phv00542329.v1.p1)
- wes_ori.or.new - Whether the tumor sample was resequenced (phv00542327.v1.p1)
- wes_source - Whether the sample was germline or tumor. (phv00542331.v1.p1)